Early and late tamoxifen resistance in breast cancer

Early and late tamoxifen resistance in breast cancer

In our study we investigated the role of the estrogen receptor (ER), progesterone receptor (PR) and clinicohistological parameters in breast cancer patients treated with tamoxifen during the early (2.5 years) vs. late (2.5-5 years) follow-up. The negative status of both ER and PR and tumors equal to...

Full description

Bibliographic Details
Main Authors: Abu Rabi Z., Markićević M., Vujasinović Tijana, Lukić Silvana, Stamatović Ljiljana, Nikolić-Vukosavljević Dragica
Format: Article
Language:English
Published: University of Belgrade, University of Novi Sad 2010-01-01
Series:Archives of Biological Sciences
Subjects:
breast cancer
estrogen receptor
progesterone receptor
prediction
resistance
Online Access:http://www.doiserbia.nb.rs/img/doi/0354-4664/2010/0354-46641002249A.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0354-4664/2010/0354-46641002249A.pdf

Similar Items